Mylan Specialty Revenue and Competitors
Estimated Revenue & Valuation
- Mylan Specialty's estimated annual revenue is currently $60.1M per year.
- Mylan Specialty's estimated revenue per employee is $201,000
Employee Data
- Mylan Specialty has 299 Employees.
- Mylan Specialty grew their employee count by -4% last year.
Mylan Specialty's People
| Name | Title | Email/Phone |
|---|
Mylan Specialty Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Mylan Specialty?
Mylan Specialty, a subsidiary of Mylan Inc. (NASDAQ: MYL), is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases, severe allergic reactions and psychiatric disorders. The company puts patients first and facilitates efficient, cost-effective partnerships with customers.
keywords:N/A
N/A
Total Funding
299
Number of Employees
$60.1M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Mylan Specialty News
Bhd and was distributed by Mylan Specialty L.P. in the United States between Dec. 9, 2021 and March 4, 2022. A missing label on Insulin Glargine...
This batch was manufactured by Biocon Sdn. Bhd. and was distributed by Mylan Specialty L.P. in the US between December 9, 2021, and March 4,...
Mylan Pharmaceuticals, now flying the Viatris banner, said Tuesday that it ... by India's Biocon and distributed nationwide by Mylan Specialty between Dec.
Other Companies in Napa
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15M | 307 | 1% | N/A |
#2 | $70M | 311 | 1% | N/A |
#3 | $75M | 324 | -9% | $10.3M |
#4 | $72.1M | 398 | 4% | N/A |
#5 | $133.3M | 425 | 19% | N/A |